Investing.com - Teva ADR reported on Thursday third quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
Teva ADR announced earnings per share of $0.58 on revenue of $3.98B. Analysts polled by Investing.com anticipated EPS of $0.58 on revenue of $4.07B.
Teva ADR shares are down 25% from the beginning of the year and are trading at $9.21 , down-from-52-week-high.They are under-performing the CAC 40 which is down 16.78% from the start of the year.
Teva ADR follows other major Healthcare sector earnings this month
Teva ADR's report follows an earnings beat by J&J on Tuesday, October 13, 2020, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on Tuesday, October 27, 2020 with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.71 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar